Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Servant

Showing results (71-80 of 129) with videos related to

Pageof 13
Sort By:
Cancers|November 27, 2019
Mechanistic Signatures of Human Papillomavirus Insertions in Anal Squamous Cell CarcinomasAdeline Morel, Cindy Neuzillet, Maxime Wack, et al.
BMC Cancer|June 3, 2011
Importance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breast cancer patientsPatricia de Cremoux, Fabien Valet, David Gentien, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2019
Improving breast cancer sensitivity to paclitaxel by increasing aneuploidySylvie Rodrigues-Ferreira, Anne Nehlig, Hadia Moindjie, et al.
Journal of Medical Genetics|June 1, 2023
Adaptive nanopore sequencing to determine pathogenicity of <i>BRCA1</i> exonic duplicationMathilde Filser, Mathias Schwartz, Kevin Merchadou, et al.
British Journal of Cancer|June 12, 2025
Genomic landscape of estrogen receptor-positive HER2-negative advanced breast cancer with acquired resistance to aromatase inhibitors: Identification of an ESR1 alteration-related gene signatureSolenn Barraud, Sophie Vacher, Camille Schiffler, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Escape from X inactivation is directly modulated by levels of Xist non-coding RNAAntonia Hauth, Jasper Panten, Emma Kneuss, et al.
Nature Cell Biology|December 15, 2025
Escape from X inactivation is directly modulated by Xist noncoding RNAAntonia Hauth, Jasper Panten, Emma Kneuss, et al.
Molecular Carcinogenesis|October 1, 2024
Methylation, Gene Expression, and Risk Genotypes at the TERT-CLPTM1L Locus in Cervical CancerDhanya Ramachandran, Qianqian Mao, Dandan Liao, et al.
British Journal of Cancer|January 5, 2024
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestaneHélène Vanacker, Isabelle Treilleux, Camille Schiffler, et al.
Briefings in Bioinformatics|September 19, 2012
A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysisMarie-Agnès Dillies, Andrea Rau, Julie Aubert, et al.
Pageof 13

Showing results (71-80 of 129) with videos related to

Sort By:
Pageof 13
Cancers|November 27, 2019
Mechanistic Signatures of Human Papillomavirus Insertions in Anal Squamous Cell CarcinomasAdeline Morel, Cindy Neuzillet, Maxime Wack, et al.
BMC Cancer|June 3, 2011
Importance of pre-analytical steps for transcriptome and RT-qPCR analyses in the context of the phase II randomised multicentre trial REMAGUS02 of neoadjuvant chemotherapy in breast cancer patientsPatricia de Cremoux, Fabien Valet, David Gentien, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2019
Improving breast cancer sensitivity to paclitaxel by increasing aneuploidySylvie Rodrigues-Ferreira, Anne Nehlig, Hadia Moindjie, et al.
Journal of Medical Genetics|June 1, 2023
Adaptive nanopore sequencing to determine pathogenicity of <i>BRCA1</i> exonic duplicationMathilde Filser, Mathias Schwartz, Kevin Merchadou, et al.
British Journal of Cancer|June 12, 2025
Genomic landscape of estrogen receptor-positive HER2-negative advanced breast cancer with acquired resistance to aromatase inhibitors: Identification of an ESR1 alteration-related gene signatureSolenn Barraud, Sophie Vacher, Camille Schiffler, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Escape from X inactivation is directly modulated by levels of Xist non-coding RNAAntonia Hauth, Jasper Panten, Emma Kneuss, et al.
Nature Cell Biology|December 15, 2025
Escape from X inactivation is directly modulated by Xist noncoding RNAAntonia Hauth, Jasper Panten, Emma Kneuss, et al.
Molecular Carcinogenesis|October 1, 2024
Methylation, Gene Expression, and Risk Genotypes at the TERT-CLPTM1L Locus in Cervical CancerDhanya Ramachandran, Qianqian Mao, Dandan Liao, et al.
British Journal of Cancer|January 5, 2024
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestaneHélène Vanacker, Isabelle Treilleux, Camille Schiffler, et al.
Briefings in Bioinformatics|September 19, 2012
A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysisMarie-Agnès Dillies, Andrea Rau, Julie Aubert, et al.
Pageof 13